Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Observational study on epilepsy in western Sweden

Official title: Prospective Regional Epilepsy Database and Biobank for Individualized Clinical Treatment

Run by Sahlgrenska University Hospital · NCT04559919 · Data updated 2026-11-12

This study looks at adults in western Sweden who have had seizures or epilepsy to see if there are specific markers or genes that can help with their diagnosis and treatment.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorSahlgrenska University Hospital
Academic / other
Locations3 sites (Borås and 2 other locations)
StatusRecruiting
StartedNovember 27, 2020
Main results expectedDecember 31, 2031
Study endsDecember 31, 2031
Registry record updatedJune 13, 2025
Trial IDNCT04559919 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years of age who have experienced an unprovoked seizure in the last year or have a diagnosis of epilepsy.

Probably not a fit

Patients with expected survival of less than two years or those unable to give informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows adults with an unprovoked seizure or epilepsy in western Sweden to identify biomarkers and genetic predispositions relevant for diagnosis and treatment. It collects baseline data and outcome variables from various patient registries, including electronic medical records and national health registers. The aim is to understand the long-term prognosis and consequences of epilepsy in this population.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnosis and treatment options for patients with epilepsy.

How similar studies have gone: Other studies have shown success in identifying biomarkers for epilepsy, making this approach promising yet still requiring further exploration.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Over 18 years of age
* An unprovoked seizure within the last year or a diagnosis of epilepsy according to the current International League Against Epilepsy definition (epilepsy with seizure in the last ten or antiepileptic drug treatment in the last five years)

Exclusion Criteria:

* Expected survival less than two years
* Inability to give informed consent

Where it's running

  • Södra Älvsborgs Sjukhus
    Borås, Sweden
    Recruiting
  • Sahlgrenska University Hospital
    Gothenburg, Sweden
    Recruiting
  • Sjukhusen i Väster
    Gothenburg, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.